Holen Sie sich die Stockscreener-App
123.74
2.05%
-2.59
Handel nachbörslich:
124.84
1.10
+0.89%
Insmed Inc Aktie (INSM) Neueste Nachrichten
Darwin Global updates Insmed Inc (INSM) ownership, reporting 3.0% beneficial stake - Stock Titan
Insmed (INSM) Q2 2026 Earnings Call Transcript - AOL.com
Insmed(INSM.US) Officer Sells US$31.96 Million in Common Stock - moomoo.com
FY2026 Earnings Forecast for Insmed Issued By HC Wainwright - MarketBeat
Handelsbanken Fonder AB Grows Stake in Insmed, Inc. $INSM - MarketBeat
Insmed (NASDAQ:INSM) COO Sells 239,850 Shares - MarketBeat
Insmed Insider Sold Shares Worth $31,964,810, According to a Recent SEC Filing - marketscreener.com
Insmed Chief Operating Officer Sold Shares Worth Over $31M - TradingView
INSMED Inc (INSM) COO exercises 239,850 options and sells matching shares - Stock Titan
HC Wainwright Brokers Increase Earnings Estimates for Insmed - MarketBeat
Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 - kalkine.ca
Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Minerva Neurosciences (NERV) and Zymeworks (ZYME) - The Globe and Mail
INSM (INSM) insider notice covers 239,850 shares and prior sales data - Stock Titan
INSM Maintained by JP Morgan -- Price Target Lowered to $175 - GuruFocus
Insmed (NASDAQ:INSM) Price Target Cut to $175.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
INSM Reiterates by Truist Securities -- Price Target Raised to $195 - GuruFocus
$1000 Invested In Insmed 5 Years Ago Would Be Worth This Much Today - Benzinga
H.C. Wainwright reiterates Buy on Insmed stock, $220 target By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Buy on Insmed stock, $220 target - Investing.com India
High Growth Tech Stocks in the US to Watch - simplywall.st
Pacer Advisors Inc. Has $1.19 Million Holdings in Insmed, Inc. $INSM - MarketBeat
Assenagon Asset Management S.A. Acquires 155,011 Shares of Insmed, Inc. $INSM - MarketBeat
Insmed Inc (INSM) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Insmed (NASDAQ:INSM) Posts Earnings Results - MarketBeat
Insmed’s New Lung Disease Study Data A Win For Company, Says Analyst - Stocktwits
Insmed (INSM) Stock Cools As BRINSUPRI Surge Recasts Growth Profile - simplywall.st
Insmed Insider Sold Shares Worth $3,494,838, According to a Recent SEC Filing - marketscreener.com
INSM Maintained by Guggenheim -- Price Target Lowered to $205 - GuruFocus
Insmed slips as investors digest a sharp post-earnings rally - Quiver Quantitative
INSM Maintained by Wells Fargo -- Price Target Raised to $169 - GuruFocus
Insmed Outlook Strengthens After Q2 Results, RBC Says - Yahoo Finance
What Insmed Stock’s Premium Is Actually Buying - Trefis
INSM Maintained by Evercore ISI Group -- Price Target Raised to $170 - GuruFocus
Has Insmed (INSM) Risen Above Fair Value After Its 3 Year Run? - finance.yahoo.com
Insmed Tops Q2 Earnings Estimates, Stock Soars 34% on Brinsupri Uptake - Zacks Investment Research
Insmed Stock: Is a Historic Drug Launch a Clear Buy Signal? - Trefis
Insmed Incorporated Q2 2026 Earnings Call Summary - finance.yahoo.com
INSM SWOT Analysis: Financial Strengths and Challenges Revealed in 10-Q Filing - GuruFocus
Quantinno Capital Management LP Grows Stock Holdings in Insmed, Inc. $INSM - MarketBeat
INSM|Insmed Inc|Price:134.620|Chg%:+3.520 - TradingKey
Insmed (INSM) Is Up 30.6% After Steeply Narrowing Losses And Raising 2026 Revenue Guidance – What’s Changed - finance.yahoo.com
Insmed (INSM) Soars 33.86% as Brinsupri Drives Fourfold Growth. Here’s What to Watch Next - finance.yahoo.com
Insmed Incorporated Stock 12‑Month Price Target Raised to $197.14, Implies 99% Upside - TradingView
Insmed Q2 Earnings Call Highlights - MarketBeat
Insmed Stock Rockets As Analysts Hike Targets On TPIP Data - StocksToTrade
INSMED INC : LEERINK PARTNERS RAISES TARGET PRICE TO $210.00 FROM $205.00 - Bitget
Insmed Catapults 34%, Leading A Biotech Rally. But Mirum Takes A Bath. - Investor's Business Daily
Reporting person for NASDAQ: INSM plans 27,173-share sale after prior trades - Stock Titan
INSMED INC : GUGGENHEIM CUTS TARGET PRICE TO $205 FROM $207 - Bitget
Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI - GuruFocus
Insmed Inc Stock (INSM) Moved Up by 31.83% on Aug 6: Key Drivers Unveiled - tradingkey.com
Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ... - Yahoo Finance
Insmed Stock Jumps As Analysts Hike Targets On TPIP Wins - StocksToTrade
Insmed Stock Pops As Analysts Hike Price Targets On TPIP, Brinsupri Momentum - StocksToTrade
Earnings call transcript: Insmed Q2 2026 revenue surge lifts stock 28% premarket - Investing.com
Insmed Sees Unusually Large Options Volume (NASDAQ:INSM) - marketbeat.com
Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales Outlook - finance.yahoo.com
Insmed (NASDAQ:INSM) Shares Gap Up After Better-Than-Expected Earnings - marketbeat.com
Insmed Shares Rise After Raising FY26 Guidance for Products - Moomoo
FMR LLC discloses 7.4% Insmed Inc (INSM) ownership in amended 13G - Stock Titan
Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks M - Benzinga
Is Insmed Inc (INSM) Positioned for Growth After Q2 Earnings Bea - GuruFocus
Insmed Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Insmed (INSM) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo Finance
Insmed Incorporated Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings Flash (INSM) Insmed Incorporated Reports Q2 Revenue $425.5M, vs. FactSet Est of $393.7M - marketscreener.com
Insmed stock surges 17% on earnings beat, raised guidance By Investing.com - Investing.com Nigeria
Insmed: Q2 Earnings Snapshot - Barchart.com
0.22%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):